Lindsay A. Marek

1.5k total citations
14 papers, 1.2k citations indexed

About

Lindsay A. Marek is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lindsay A. Marek has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Lindsay A. Marek's work include Fibroblast Growth Factor Research (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer therapeutics and mechanisms (2 papers). Lindsay A. Marek is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer therapeutics and mechanisms (2 papers). Lindsay A. Marek collaborates with scholars based in United States, Poland and India. Lindsay A. Marek's co-authors include Lynn E. Heasley, Trista K. Hinz, Kathryn E. Ware, Katherine R. Singleton, Aik Choon Tan, Barbara A. Helfrich, Emily K. Kleczko, Robert A. Winn, Raphael A. Nemenoff and Paul A. Bunn and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Lindsay A. Marek

14 papers receiving 1.1k citations

Peers

Countries citing papers authored by Lindsay A. Marek

Since Specialization

Citations

This map shows the geographic impact of Lindsay A. Marek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay A. Marek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay A. Marek more than expected).

Fields of papers citing papers by Lindsay A. Marek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay A. Marek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay A. Marek. The network helps show where Lindsay A. Marek may publish in the future.

Co-authorship network of co-authors of Lindsay A. Marek

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay A. Marek. A scholar is included among the top collaborators of Lindsay A. Marek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay A. Marek. Lindsay A. Marek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines 2019 ·Molecular Pharmacology ·Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, (unknown), Lindsay A. Marek, Jihye Kim, Aik Choon Tan, Lynn E. Heasley	5
2	EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases 2017 ·Cancer Research ·Aria Vaishnavi, Laura Schubert, Uwe Rix, Lindsay A. Marek, Anh T. Le, Stephen B. Keysar, Magdalena J. Glogowska, Matthew A. Smith, Severine Kako, Natália J. Sumi, Kurtis D. Davies, Kathryn E. Ware, Marileila Varella‐Garcia, Eric B. Haura, Antonio Jimeno, Lynn E. Heasley, Dara L. Aisner, Robert C. Doebele	61
3	Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC 2015 ·Cancer Research ·Katherine R. Singleton, Trista K. Hinz, Emily K. Kleczko, Lindsay A. Marek, Jeff Kwak, (unknown), Jihye Kim, Aik Choon Tan, Lynn E. Heasley	47
4	Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma 2014 ·Molecular Cancer Research ·Lindsay A. Marek, Trista K. Hinz, Anne von Mäßenhausen, (unknown), Emily K. Kleczko, Diana Boehm, Mary C. Weiser-Evans, Raphael A. Nemenoff, Hans Hoffmann, Arne Warth, Joseph M. Gozgit, Sven Perner, Lynn E. Heasley	33
5	FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies 2014 ·Clinical Cancer Research ·Murry W. Wynes, Trista K. Hinz, Dexiang Gao, Michael L. Martini, Lindsay A. Marek, Kathryn E. Ware, (unknown), Diana Böhm, Sven Perner, Barbara A. Helfrich, Rafał Dziadziuszko, Jacek Jassem, Szymon Wojtylak, Aleksandra Sejda, Joseph M. Gozgit, Paul A. Bunn, D. Ross Camidge, Aik Choon Tan, Fred R. Hirsch, Lynn E. Heasley	125
6	A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop 2013 ·Oncogenesis ·(unknown), Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Lindsay A. Marek, B. Helfrich, Christopher T. Cummings, Douglas K. Graham, David P. Astling, Aik Choon Tan, Lynn E. Heasley	203
7	A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines 2013 ·Molecular Pharmacology ·Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás‐Selves, Clark M. Hatheway, Aik Choon Tan, James DeGregori, Lynn E. Heasley	30
8	Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells 2011 ·Clinical Cancer Research ·(unknown), Trista K. Hinz, Scott A. Kono, Katherine R. Singleton, (unknown), Kathryn E. Ware, Lindsay A. Marek, Barbara Frederick, David Raben, Lynn E. Heasley	84
9	Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression 2010 ·PLoS ONE ·Kathryn E. Ware, (unknown), Lydia R. Heasley, Lindsay A. Marek, Trista K. Hinz, (unknown), Barbara A. Helfrich, Robert C. Doebele, Lynn E. Heasley	123
10	Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells 2008 ·Molecular Pharmacology ·Lindsay A. Marek, Kathryn E. Ware, (unknown), (unknown), (unknown), Jennifer E. Smith, Lee McDermott, Christopher D. Coldren, Raphael A. Nemenoff, Daniel T. Merrick, Barbara A. Helfrich, Paul A. Bunn, Lynn E. Heasley	180
11	Restoration of Wnt-7a Expression Reverses Non-small Cell Lung Cancer Cellular Transformation through Frizzled-9-mediated Growth Inhibition and Promotion of Cell Differentiation 2005 ·Journal of Biological Chemistry ·Robert A. Winn, Lindsay A. Marek, Sun‐Young Han, Karen J. Rodriguez, (unknown), (unknown), Michelle Van Scoyk, (unknown), (unknown), Nicholas P. Barry, Yvette Bren‐Mattison, Terence J. Van Raay, Raphael A. Nemenoff, Lynn E. Heasley	140
12	Inhibited Neurogenesis in JNK1-Deficient Embryonic Stem Cells 2005 ·Molecular and Cellular Biology ·Claudia R. Amura, Lindsay A. Marek, Robert A. Winn, Lynn E. Heasley	54
13	Multiple signaling conduits regulate global differentiation‐specific gene expression in PC12 cells 2004 ·Journal of Cellular Physiology ·Lindsay A. Marek, (unknown), Claudia R. Amura, (unknown), Vicki Van Putten, Raphael A. Nemenoff, Lynn E. Heasley	35
14	Regulation of Platinum-Compound Cytotoxicity by the c-Jun N-Terminal Kinase and c-Jun Signaling Pathway in Small-Cell Lung Cancer Cells 2002 ·Molecular Pharmacology ·(unknown), Lindsay A. Marek, (unknown), Lynn E. Heasley	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact